Form 8-K - Current report:
SEC Accession No. 0001193125-22-082890
Filing Date
2022-03-23
Accepted
2022-03-23 17:25:21
Documents
52
Period of Report
2022-03-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d341975d8k.htm   iXBRL 8-K 39864
2 EX-99.1 d341975dex991.htm EX-99.1 29759
3 EX-99.2 d341975dex992.htm EX-99.2 49119
4 EX-99.3 d341975dex993.htm EX-99.3 36895
8 GRAPHIC g341975ex99_2p10g1.jpg GRAPHIC 481858
9 GRAPHIC g341975ex99_2p11g1.jpg GRAPHIC 477967
10 GRAPHIC g341975ex99_2p12g1.jpg GRAPHIC 383426
11 GRAPHIC g341975ex99_2p13g1.jpg GRAPHIC 338824
12 GRAPHIC g341975ex99_2p14g1.jpg GRAPHIC 305122
13 GRAPHIC g341975ex99_2p15g1.jpg GRAPHIC 381263
14 GRAPHIC g341975ex99_2p16g1.jpg GRAPHIC 422327
15 GRAPHIC g341975ex99_2p17g1.jpg GRAPHIC 396797
16 GRAPHIC g341975ex99_2p18g1.jpg GRAPHIC 351580
17 GRAPHIC g341975ex99_2p19g1.jpg GRAPHIC 316486
18 GRAPHIC g341975ex99_2p1g1.jpg GRAPHIC 419665
19 GRAPHIC g341975ex99_2p20g1.jpg GRAPHIC 353253
20 GRAPHIC g341975ex99_2p21g1.jpg GRAPHIC 447471
21 GRAPHIC g341975ex99_2p22g1.jpg GRAPHIC 356307
22 GRAPHIC g341975ex99_2p23g1.jpg GRAPHIC 553610
23 GRAPHIC g341975ex99_2p24g1.jpg GRAPHIC 425321
24 GRAPHIC g341975ex99_2p25g1.jpg GRAPHIC 376103
25 GRAPHIC g341975ex99_2p26g1.jpg GRAPHIC 388327
26 GRAPHIC g341975ex99_2p27g1.jpg GRAPHIC 335890
27 GRAPHIC g341975ex99_2p28g1.jpg GRAPHIC 385892
28 GRAPHIC g341975ex99_2p29g1.jpg GRAPHIC 371389
29 GRAPHIC g341975ex99_2p2g1.jpg GRAPHIC 707785
30 GRAPHIC g341975ex99_2p30g1.jpg GRAPHIC 341138
31 GRAPHIC g341975ex99_2p31g1.jpg GRAPHIC 363187
32 GRAPHIC g341975ex99_2p32g1.jpg GRAPHIC 328814
33 GRAPHIC g341975ex99_2p33g1.jpg GRAPHIC 443163
34 GRAPHIC g341975ex99_2p34g1.jpg GRAPHIC 423623
35 GRAPHIC g341975ex99_2p35g1.jpg GRAPHIC 338293
36 GRAPHIC g341975ex99_2p3g1.jpg GRAPHIC 551540
37 GRAPHIC g341975ex99_2p4g1.jpg GRAPHIC 421286
38 GRAPHIC g341975ex99_2p5g1.jpg GRAPHIC 466324
39 GRAPHIC g341975ex99_2p6g1.jpg GRAPHIC 453103
40 GRAPHIC g341975ex99_2p7g1.jpg GRAPHIC 349053
41 GRAPHIC g341975ex99_2p8g1.jpg GRAPHIC 423347
42 GRAPHIC g341975ex99_2p9g1.jpg GRAPHIC 337652
43 GRAPHIC g341975g0324010413078.jpg GRAPHIC 2520
44 GRAPHIC g341975g0324010417031.jpg GRAPHIC 2292
  Complete submission text file 0001193125-22-082890.txt   19920634

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA lgnd-20220323.xsd EX-101.SCH 2854
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE lgnd-20220323_lab.xml EX-101.LAB 17995
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lgnd-20220323_pre.xml EX-101.PRE 11260
46 EXTRACTED XBRL INSTANCE DOCUMENT d341975d8k_htm.xml XML 3404
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 22763956
SIC: 2834 Pharmaceutical Preparations